Form 4: Natera Officer Sells Shares Under 10b5-1 Plan

Natera, Inc. reports that its SEC and Chief Legal Officer, Daniel Rabinowitz, sold a total of 17,994 shares of common stock on July 1, 2026, through a pre-arranged Rule 10b5-1 trading plan.

Summary

• Daniel Rabinowitz, SEC and Chief Legal Officer of Natera, Inc., executed a series of stock sales on July 1, 2026.
• These transactions involved the sale of common stock totaling 17,994 shares.
• The sales were conducted under a Rule 10b5-1 trading plan, adopted by Rabinowitz on December 5, 2025.
• The sales occurred at a weighted average price, with individual transaction prices ranging from $266.33 to $278.78 per share.
• Following these transactions, Rabinowitz beneficially owns 172,294 shares of Natera's common stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing due to the significant volume of shares sold by a key executive, despite the use of a 10b5-1 plan.

Positives

• The sales were executed under a Rule 10b5-1 plan, indicating pre-planned and potentially non-insider trading related activity.
• The reporting person continues to hold a significant number of shares (172,294) after the sales.

Negatives

• A significant number of shares (17,994) were sold by a key executive.
• The total value of the shares sold is substantial, reflecting a considerable divestment.

Risks

• Potential for negative market perception due to a large sale by a senior executive, even if conducted under a 10b5-1 plan.
• The weighted average pricing across multiple transactions suggests a strategy to manage market impact, but the overall downward pressure on price from selling a large block remains.

Future Outlook

This filing does not contain forward-looking statements or guidance. It reports on past transactions.

Management Comments

• The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
• The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from [specific ranges provided in footnotes] per share, inclusive.
• The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Industry Context

StockSavvy.ai notes that insider selling, even under a 10b5-1 plan, can sometimes be interpreted by the market as a signal of reduced confidence, although the existence of the plan itself is designed to mitigate this perception by demonstrating pre-planned, systematic selling. For companies in the biotechnology and diagnostics sector like Natera, significant insider transactions are closely watched.

Stakeholder Impact

• Shareholders may view the sale by a senior executive with some concern, potentially impacting short-term stock sentiment.
• Employees holding stock options or grants may be influenced by the executive's decision to sell.
• Creditors and suppliers are unlikely to be directly impacted by this specific transaction.

Key Dates

Recommendation

The filing reports a significant sale of stock by a key executive under a pre-established 10b5-1 plan. While insider selling can be a negative signal, the use of the plan mitigates concerns about immediate non-public information. The executive still retains a substantial number of shares. Without further context on Natera's financial performance or strategic outlook, a 'hold' recommendation is prudent, suggesting investors monitor future filings and company performance.

Keywords

Natera Inc, NTRA, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Daniel Rabinowitz, SEC and Chief Legal Officer, Beneficial Ownership, Common Stock